531686
ADVIKLA
Start SIP
Invest Now
Start SIP in ADVIKLA
Performance
- Low
- ₹2
- High
- ₹2
- 52 Week Low
- ₹2
- 52 Week High
- ₹4
- Open Price₹2
- Previous Close₹2
- Volume1,011
- 50 DMA₹2.47
- 100 DMA₹2.66
- 200 DMA₹2.50
Investment Returns
- Over 1 Month 0%
- Over 3 Month -15.38%
- Over 6 Month -38.46%
- Over 1 Year -58.19%
Smart Investing Starts Here Start SIP with MPS Pharma for Steady Growth!
MPS Pharma Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- -3.8
- PEG Ratio
- -4.2
- Market Cap Cr
- 3
- P/B Ratio
- 5.2
- Average True Range
- 0.09
- EPS
- -
- Dividend Yield
- 0
- MACD Signal
- -0.27
- RSI
- 26.38
- MFI
- 19.18
MPS Pharma Financials
MPS Pharma Technicals
EMA & SMA
Current Price
₹1.76
-0.09
(-4.86%)
- Bearish Moving Average 16
- Bullish Moving Average 0
- 20 Day
- ₹2.01
- 50 Day
- ₹2.47
- 100 Day
- ₹2.66
- 200 Day
- ₹2.50
Resistance and Support
1.77
- R3 1.83
- R2 1.81
- R1 1.79
- S1 1.75
- S2 1.73
- S3 1.71
MPS Pharma Corporate Actions - Bonus, Splits, Dividends
| Date | Purpose | Remarks |
|---|---|---|
| 2025-11-14 | Quarterly Results | |
| 2025-09-02 | A.G.M. | |
| 2025-08-12 | Quarterly Results | |
| 2025-05-28 | Audited Results | |
| 2025-02-12 | Quarterly Results |
MPS Pharma F&O
About MPS Pharma
- NSE Symbol
- ADVIKLA
- BSE Symbol
- 531686
- Managing Director
- Mr. Peeyush Kumar Aggarwal
- ISIN
- INE537C01019
Similar Stocks to MPS Pharma
MPS Pharma FAQs
MPS Pharma share price is ₹1 As on 12 January, 2026 | 10:44
The Market Cap of MPS Pharma is ₹3.4 Cr As on 12 January, 2026 | 10:44
The P/E ratio of MPS Pharma is -3.8 As on 12 January, 2026 | 10:44
The PB ratio of MPS Pharma is 5.2 As on 12 January, 2026 | 10:44
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.